West Pharmaceutical Services 2Q08 2Q Revenues: $279.3 million (+6%) 2Q Earnings: $28.7 million (+8%) YTD Revenues: $550.0 million (+6%) YTD Earnings: $55.0 million (+4%) Comments: Revenues from the Pharmaceutical Systems unit were up 12% to $212.6 million, but were adversely affected by the slowdown in ESA drugs, including Amgen’s Epogen. In addition, two-thirds of that unit’s revenue growth derived from the weak dollar. Sales at the Tech Group unit dropped $8.1 millio...